Calton & Associates, Inc. Galapagos Nv Transaction History

Calton & Associates, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$143.0 - $274.03 $217,932 - $417,621	-1,524 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$146.12 - $215.82 $4,529 - $6,690	31 Added 2.08%	1,524 $315,000
Q3 2019 Nov 07, 2019	BUY	$130.44 - $187.64 $194,746 - $280,146	1,493 New	1,493 $228,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Calton & Associates, Inc. with notifications on news.